Kevin J. Whaley

8.1k total citations
103 papers, 5.1k citations indexed

About

Kevin J. Whaley is a scholar working on Biotechnology, Immunology and Infectious Diseases. According to data from OpenAlex, Kevin J. Whaley has authored 103 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Biotechnology, 40 papers in Immunology and 21 papers in Infectious Diseases. Recurrent topics in Kevin J. Whaley's work include Transgenic Plants and Applications (44 papers), Toxin Mechanisms and Immunotoxins (21 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Kevin J. Whaley is often cited by papers focused on Transgenic Plants and Applications (44 papers), Toxin Mechanisms and Immunotoxins (21 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Kevin J. Whaley collaborates with scholars based in United States, Austria and United Kingdom. Kevin J. Whaley's co-authors include Richard A. Cone, Thomas R. Moench, Larry Zeitlin, Elizabeth R. Boskey, Stuart S. Olmsted, Michael Pauly, W. Mark Saltzman, M. Radomsky, Ashley I. Yudin and Andrew Hiatt and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Kevin J. Whaley

101 papers receiving 4.9k citations

Peers

Countries citing papers authored by Kevin J. Whaley

Since Specialization

Citations

This map shows the geographic impact of Kevin J. Whaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Whaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Whaley more than expected).

Fields of papers citing papers by Kevin J. Whaley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Whaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Whaley. The network helps show where Kevin J. Whaley may publish in the future.

Co-authorship network of co-authors of Kevin J. Whaley

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Whaley. A scholar is included among the top collaborators of Kevin J. Whaley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Whaley. Kevin J. Whaley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium 2024 ·Frontiers in Immunology ·Kohei Togami, Whitney Wolf, (unknown), (unknown), Limei Shen, Alison Schaefer, Kenichi Okuda, Larry Zeitlin, Michael Pauly, Kevin J. Whaley, Raymond J. Pickles, Samuel K. Lai	2
2	Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial 2021 ·PLoS Medicine ·Joseph A. Politch, Susan Cu‐Uvin, Thomas R. Moench, Karen T. Tashima, Jai Marathe, Kate M. Guthrie, Howard Cabral, (unknown), Miles B. Brennan, Larry Zeitlin, Hans Spiegel, Kenneth H. Mayer, Kevin J. Whaley, Deborah J. Anderson	40
3	Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody 2021 ·Proceedings of the National Academy of Sciences ·Larry Zeitlin, Robert W. Cross, Joan B. Geisbert, Viktoriya Borisevich, Krystle N. Agans, Abhishek N. Prasad, Sven Enterlein, M. Javad Aman, Zachary A. Bornholdt, Miles B. Brennan, (unknown), Do Hyoung Kim, (unknown), Crystal L. Moyer, Michael Pauly, William S. Shestowsky, Kevin J. Whaley, Karla A. Fenton, Thomas W. Geisbert	14
4	Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing 2021 ·Human Vaccines & Immunotherapeutics ·Kevin J. Whaley, Larry Zeitlin	19
5	Manufacturing plant-made monoclonal antibodies for research or therapeutic applications 2021 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Kelsi Swope, Josh Morton, Gregory P. Pogue, (unknown), Michael Pauly, John Shepherd, Carrie A. Simpson, Barry Bratcher, Kevin J. Whaley, Larry Zeitlin, Keith Davis, Hugh Haydon	8
6	Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies 2020 ·PLoS neglected tropical diseases ·(unknown), (unknown), (unknown), John J. Varrone, Graham G. Willsey, Michael Pauly, Kevin J. Whaley, Larry Zeitlin, Nicholas J. Mantis	22
7	Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin 2020 ·npj Vaccines ·Chad J. Roy, Greta Van Slyke, Dylan Ehrbar, Zachary A. Bornholdt, Miles B. Brennan, (unknown), Michelle Chen, Do Hyoung Kim, (unknown), Kevin J. Whaley, Jeffrey W. Froude, Fernando Torres‐Velez, Ellen S. Vitetta, Peter J. Didier, Lara Doyle‐Meyers, Larry Zeitlin, Nicholas J. Mantis	11
8	ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus 2018 ·The Journal of Infectious Diseases ·Bing Yang, Alison Schaefer, Yingying Wang, Justin McCallen, Phoebe Lee, Jay Newby, Harendra Arora, Priya A. Kumar, Larry Zeitlin, Kevin J. Whaley, Scott A. McKinley, William A. Fischer, (unknown), Samuel K. Lai	26
9	Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition 2018 ·Mucosal Immunology ·Holly A. Schroeder, Kenetta L. Nunn, Alison Schaefer, (unknown), Felix Lam, Michael Pauly, Kevin J. Whaley, Larry Zeitlin, (unknown), Jacques Ravel, Samuel K. Lai	31
10	Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody 2017 ·Science Translational Medicine ·Chad E. Mire, Joan B. Geisbert, Viktoriya Borisevich, Karla A. Fenton, Krystle N. Agans, Andrew I. Flyak, Daniel J. Deer, Herta Steinkellner, Ognian Bohorov, Natasha Bohorova, Charles Goodman, Andrew Hiatt, (unknown), Michael Pauly, Jesús Velasco, Kevin J. Whaley, James E. Crowe, Larry Zeitlin, Thomas W. Geisbert	69
11	Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV 2017 ·AIDS ·Deborah J. Anderson, Joseph A. Politch, Larry Zeitlin, (unknown), (unknown), Kenneth H. Mayer, Ruth M. Ruprecht, François Villinger, Kevin J. Whaley	21
12	Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide 2015 ·Journal of Immunological Methods ·(unknown), (unknown), Michael Pauly, Do H. Kim, Ognian Bohorov, Natasha Bohorova, Kevin J. Whaley, Larry Zeitlin, Nicholas J. Mantis	8
13	Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model 2013 ·mAbs ·Larry Zeitlin, Ognian Bohorov, Natasha Bohorova, Andrew Hiatt, Do Kim, Michael Pauly, Jesús Velasco, Kevin J. Whaley, Dale L. Barnard, John T. Bates, James E. Crowe, Pedro A. Piedra, Brian E. Gilbert	24
14	Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit 2011 ·Vaccine ·Joanne M. O’Hara, Kevin J. Whaley, Michael Pauly, Larry Zeitlin, Nicholas J. Mantis	30
15	Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines 2010 ·Antiviral Research ·Kevin J. Whaley, Justin Hanes, Robin J. Shattock, Richard A. Cone, David R. Friend	75
16	Preventing Sexual Transmission of HSV and HIV: the Challenge for Active and Passive Immunization of Mucosal Surfaces 2002 ·Biotechnology and Genetic Engineering Reviews ·Larry Zeitlin, (unknown), Kevin J. Whaley	2
17	Preventing infectious disease with passive immunization 2000 ·Microbes and Infection ·Larry Zeitlin, Richard A. Cone, Thomas R. Moench, Kevin J. Whaley	67
18	Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina 1998 ·Journal of Reproductive Immunology ·Larry Zeitlin, Philip E. Castle, Kevin J. Whaley, Thomas R. Moench, Richard A. Cone	7
19	Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine 1987 ·Immunology ·Kevin J. Whaley	17
20	Fatal Subaxial Dislocation of Cervical Spine in Rheumatoid Arthritis 1968 ·BMJ ·Kevin J. Whaley, W C Dick	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact